Importance of T-cell location rekindled: implication for tuberculosis vaccination strategies

References

• McShane H, Hill A. Prime–boost immunisation strategies for tuberculosis. Microbes Infect.7, 962–967 (2005).
   PubMed Web of Science ®Google Scholar
• Xing Z, Charters TJ. Heterologous boost vaccines for bacillus Calmette–Guérin prime immunization against tuberculosis. Expert Rev. Vaccines6(4), 539–546 (2007).
   PubMed Web of Science ®Google Scholar
• Aagaard C, Dietrich J, Doherty M, Andersen P. TB vaccines: current status and future perspectives. Immunol. Cell. Biol.87, 279–286 (2009).
   PubMed Web of Science ®Google Scholar
• Xing Z, Lichty BD. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis (Edinb.)86, 211–217 (2006).
   PubMed Web of Science ®Google Scholar
• Andersen P. Tuberculosis vaccines – an update. Nat. Rev. Microbiol.5, 484–487 (2007).
   PubMed Web of Science ®Google Scholar
• Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev. Vaccines7(5), 635–650 (2008).
   PubMed Web of Science ®Google Scholar
• Chen L, Wang J, Zganiacz A, Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun.72, 238–246 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L, Wong YL, Muttil P et al. Immunization by a bacterial aerosol. Proc. Natl Acad. Sci. USA105, 4656–4660 (2008).
   PubMed Web of Science ®Google Scholar
• Dietrich J, Andersen C, Rappuoli R et al. Mucosal administration of Ag85B–ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette–Guérin immunity. J. Immunol.177, 6353–6360 (2006).
   PubMed Web of Science ®Google Scholar
• Rosada RS, de la Torre LG, Frantz FG et al. Protection against tuberculosis by a single intranasal administration of DNA–hsp65 vaccine complexed with cationic liposomes. BMC Immunol.9, 38 (2008).
   PubMed Web of Science ®Google Scholar
• Radosevic K, Wieland CW, Rodriguez A et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of g interferon. Infect. Immun.75, 4105–4115 (2007).
   PubMed Web of Science ®Google Scholar
• Stukova MA, Sereinig S, Zabolotnyh NV et al. Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb.)86, 236–246 (2006).
   PubMed Web of Science ®Google Scholar
• Goonetilleke NP, McShane H, Hannan CM et al. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette–Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol.171, 1602–1609 (2003).
   PubMed Web of Science ®Google Scholar
• Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z. Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus vectored vaccine for pulmonary tuberculosis. Mol. Ther.16, 1161–1169 (2008).
   PubMed Web of Science ®Google Scholar
• Wang J, Thorson L, Stokes RW et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol.173, 6357–6365 (2004).
   PubMed Web of Science ®Google Scholar
• Mu J, Jeyanathan M, Small CL et al. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis. Mol. Ther.17, 1093–1100 (2009).
   PubMed Web of Science ®Google Scholar
• Forbes EK, Sander C, Ronan EO et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol.181, 4955–4964 (2008).
   PubMed Web of Science ®Google Scholar
• Kallenius G, Pawlowski A, Brandtzaeg P, Svenson S. Should a new tuberculosis vaccine be administered intranasally? Tuberculosis (Edinb.)87, 257–266 (2007).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat. Med.11, S45–S53 (2005).
   PubMed Web of Science ®Google Scholar
• Kohlmeier JE, Woodland DL. Memory T cell recruitment to the lung airways. Curr. Opin. Immunol.18, 357–362 (2006).
   PubMed Web of Science ®Google Scholar
• Beverley PC, Tchilian EZ. Lessons for tuberculosis vaccines from respiratory virus infection. Expert Rev. Vaccines7(8), 1165–1172 (2008).
   PubMed Web of Science ®Google Scholar
• Cooper AM. T cells in mycobacterial infection and disease. Curr. Opin. Immunol.21, 378–384 (2009).
   PubMed Web of Science ®Google Scholar
• Cooper AM. Cell-mediated immune responses in tuberculosis. Ann. Rev. Immunol.27, 393–422 (2009).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, McCormick S, Roediger E et al. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J. Immunol.178, 2387–2395 (2007).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, Zhang X, McCormick S et al. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol.174, 7986–7994 (2005).
   PubMed Web of Science ®Google Scholar
• McCormick S, Santosuosso M, Small C-L et al. mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous antigen presenting cells. J. Immunol.181, 2356–2367 (2008).
   PubMed Web of Science ®Google Scholar
• Jeyanathan M, Mu J, Kugathasan K et al. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of pro-inflammatory signals in the lung. J. Immunol.181, 5618–5626 (2008).
   PubMed Web of Science ®Google Scholar
• Elvang T, Christensen JP, Billeskov R et al. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS ONE4, e5139 (2009).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun.74, 4634–4643 (2006).
   PubMed Web of Science ®Google Scholar
• Mittrücker HW, Steinhoff U, Köhler A et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Natl Acad. Sci. USA104, 12434–12439 (2007).
   PubMed Web of Science ®Google Scholar
• Xing Z, McFarland CT, Sallenave JM et al. Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis. PLoS ONE4, e5856 (2009).
   PubMed Web of Science ®Google Scholar
• Vordermeier HM, Villarreal-Ramos B, Cockle PJ et al. Heterologous prime–boost vaccination strategies based on BCG and viral booster vaccines improved BCG induced protection in cattle against bovine tuberculosis. Infect. Immun.77, 3364–3373 (2009).
   PubMed Web of Science ®Google Scholar